Next Article in Journal
Time-Restricted Eating and Bone Health: A Systematic Review with Meta-Analysis
Previous Article in Journal
Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 16
Issue 6
10.3390/nu16060875
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary Intakes of Long-Chain Polyunsaturated Fatty Acids and Impulsivity: Comparing Non-Restricted, Vegetarian, and Vegan Diets

by
Mitchell K. Byrne
1,
Rebecca Cook
1,
Janina C. D. Murta
1,
Daniel Bressington
1,2 and
Barbara J. Meyer
3,4,*
1
Faculty of Health, Charles Darwin University, Ellengowan Drive, Darwin, NT 0810, Australia
2
Faculty of Nursing, Chiang Mai University, 110/406 Inthawaroros Road, Sri Phum District, Chiang Mai 50200, Thailand
3
School of Medical, Indigenous and Health Sciences, Lipid Research Centre, Molecular Horizons, University of Wollongong, Wollongong, NSW 2522, Australia
4
Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia
*
Author to whom correspondence should be addressed.
Nutrients 2024, 16(6), 875; https://doi.org/10.3390/nu16060875
Submission received: 6 February 2024 / Revised: 8 March 2024 / Accepted: 15 March 2024 / Published: 18 March 2024
(This article belongs to the Section Lipids)
Versions Notes

Abstract

:
Background: Research suggests a link between deficiencies in omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) and impulsivity among psychiatric populations. However, this association is less evident in non-clinical populations. As omega-3 LCPUFAs are predominantly sourced through fish consumption, non-fish dieters may be more vulnerable to higher impulsivity. Methods: This cross-sectional observational study explored the association between lower intakes of omega-3 LCPUFA food sources and higher self-reported measures of impulsivity among healthy adults consuming non-restricted, vegetarian, and vegan diets. Results: The results from the validated Food Frequency Questionnaire showed significantly lower estimated omega-3 LCPUFA intakes among vegans and vegetarians when compared with people consuming non-restricted diets. Furthermore, although all groups scored within the normal range of impulsivity measures, vegans scored comparatively higher. Vegans also scored significantly higher in impulsivity control relating to attention than those consuming non-restricted diets. Conclusions: The significantly lower omega-3 LCPUFA dietary intakes in the vegan diets were associated with higher scores in the second-order attentional aspect of self-reported impulsiveness.

1. Introduction

There is growing recognition of the relationship between diet and mental health, particularly the beneficial role of omega-3 LCPUFAs in improving the main symptom dimensions in psychiatric populations, including impulsivity. Impulsivity is arguably associated with the most significant number of mental health conditions in clinical and non-clinical populations [1]. According to the fifth edition of the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the disinhibitory trait of impulsivity is characteristic of 18 disorders, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and bipolar disorder (BPD) [2].
In clinical and non-clinical populations, impulsivity can present in various forms, including attention deficit, poor concentration, high risk-taking, poor decision-making, and unplanned or socially unfavourable reactive behaviour [3]. These behavioural and cognitive presentations impair everyday functioning and can have adverse social consequences regarding education, employment, and personal relationships [1]. Thus, impulsivity is an important target for intervention [3].
Despite progress in the development of pharmacological treatments to help manage symptoms of clinical impulsiveness, some studies suggest that they may be unfavourable due to adverse effects, including appetite loss, insomnia, abdominal pains, long-term safety concerns and unsuitability for use in sub-clinical populations [4,5]. At the same time, there is growing interest in non-pharmacological approaches to address impulsive behaviours. Omega-3 LCPUFAs, which are widely studied as important nutrients for brain function and supplementation in mental health disorders [6], are now being widely tested as potential nutraceuticals for improving impulsive behaviour [7].
This growing research interest builds on previous evidence indicating a relationship between omega-3 LCPUFA deficiency and impulsivity-related issues including aggression, hostility [8,9], poorer cognitive performance [10,11,12], psychopathologies [6,13,14,15], and self-regulation disorders such as attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BPD), and anti-social personality disorder and aggression [8,9,16,17]. It also builds on research suggesting that the core executive function of impulse control requires the efficient functioning of the prefrontal cortex [18], which in turn requires an adequate balance of omega-3 LCPUFAs and omega-6 LCPUFAs for optimal operation [19]. These two families of LCPUFAs include omega-3 eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA) and its precursor, alpha-linolenic acid (ALA), and omega-6 arachidonic acid (AA) and its precursor linoleic acid (LA) [20].
Studies involving nutrition and mental health consistently indicate that while the optimal balance of n-3 and n-6 is 1:1, the globally predominant Western diet (with a high energy content and low nutritional value) is misaligned with our genetic disposition, at a balance of approximately 1:16–20 [21,22,23]. Additionally, although preferential diets such as vegan and vegetarian are healthy in that they are lower in total fats, cholesterol, and saturated fats, they tend to show greater deficiencies of n-3 and higher concentrations of n-6 when compared to non-restricted diets [24]. The exclusion of fish may result in n-3 LCPUFA deficiencies and a predisposition toward greater impulsivity [24].
There is emerging evidence showing that omega-3 LCPUFA supplementation can have a beneficial effect in addressing impulsivity [15]. However, research regarding the benefits of omega-3 LCPUFAs for the management of mental health conditions in the general population is less widely explored [10].
This study aimed to investigate the unexplored association between the dietary intake of omega-3 LCPUFAs in restricted diets and the levels of trait impulsivity using a cross-sectional and quantitative approach among the general adult population. It was hypothesised that participants following vegan and vegetarian diets would show lower estimated omega-3 LCPUFA dietary intakes than the non-restricted dietary group. It was also hypothesised that participants following vegan and vegetarian diets would score higher in the self-reported measures of impulsivity compared to the non-restricted diet group.

2. Materials and Methods

2.1. Study Design

The current cross-sectional observational study used a between-subject design for the comparison of means (or median for non-normally distributed data) [25]. The independent variable was the usual diet type, consisting of three groups: non-restricted, vegetarian, and vegan. The dependent variables measured included total and breakdown estimates of omega-3 (ALA, EPA, DPA and DHA), and omega-6 (LA and AA), and a self-reported measure of trait impulsivity, yielding a total and sub score of three second-order factors (attentional, motor, and non-planning).

2.2. Participants

This study was approved by the Charles Darwin University Human Research Ethics Committee (H21040). To determine group differences based on dietary omega-3 estimates in impulsivity scores, an a priori power analysis for the primary outcome using G*Power [26] was conducted with input parameters indicating the power (1 − β) set at 0.95, the effect size f set at 0.25, and the err probability α set at 0.05 for three groups. The output generated indicated that the total sample size would need to be N = 252 for group differences to reach statistical significance at the 0.05 level.
A total of 695 healthy Australian adult volunteers aged 18 years and over responded to an online invitation via Qualtrics to participate in an anonymous survey investigating diet and self-regulation. All data were collected and stored following corresponding research management procedures, including obligations under the 2018 National Statement on Ethical Conduct in Human Research. No incentive to participate was offered.
The initial sampling method [27] began as non-target-specific, belonging to the convenience/snowball type, with volunteers invited to share the survey invitation link. However, a significant difference in group sizes became apparent early in the recruitment stage. Ethics approval was sought and granted to amend the sampling method from random to stratified, targeting vegan and vegetarian interest groups to balance group sizes.

2.3. Questionnaires

The Qualtrics online survey platform was the preferred option to achieve optimal data for analysis, providing both response quality and expert review functions, including Internet BOT (robot) detection (i.e., a software application to imitate human internet activity), fraudulent/duplicate responding, and poor completion (https://www.qualtrics.com/) (accessed on 22 July 2022).
The polyunsaturated fatty acid food frequency questionnaire (PUFA FFQ) is an expanded electronic version of the original and the first of its kind, developed in 2008 by Sullivan and colleagues [28,29], providing a comprehensive list of Australian foods containing LCPUFAs [30]. The results from the PUFA FFQ were calculated automatically, providing quantitative total amounts (expressed as grams per 100 g of edible portion) for ALA, EPA, DPA and DHA, and omega-6 LA and AA.
To determine “true intake”, the triad method was used, which is a statistical model which uses a triangular comparison between the questionnaire, the reference method (3-day weighed food records) and a biomarker (in this case [30], both plasma and erythrocytes were used as biomarkers). The closer the validity coefficient is to 1, the closer the intake estimated by the dietary assessment is to the “true intake”. The validity coefficient for the “true intake” of the PUFA FFQ was 0.78 and the validity coefficient for the “true intake” of the erythrocyte omega-3 LCPUFA was 0.79. Furthermore, reproducibility was assessed 2 to 4 months after the first PUFA FFQ and the second PUFA FFQ and the Spearman correlation coefficient was 0.85, showing that the PUFA FFQ was reproducible. Moreover, the study participants in these validation studies [28,29,30] consumed varied diets, including vegan, vegetarian and non-restricted diets, hence the PUFA FFQ was validated for use with people consuming these diets.
Furthermore, this PUFA FFQ was compared to a generic FFQ using the triad method and the validity coefficient of the “true intake” of the PUFA FFQ was 0.78 compared to the generic FFQ validity coefficient of 0.23 [31], demonstrating that the PUFA FFQ is superior to generic FFQ to determine omega-3 LCPUFAs.
Therefore, the PUFA FFQ is reproducible and has been validated for blood omega-3 LCPUFAs, and hence it can be used in research without the need to take blood samples to measure dietary omega-3 LCPUFA intake [28,29,30].
The 30-item self-report Barratt Impulsiveness Scale (BIS-11), one of the most common measures used in mental health research, was developed to measure the disinhibitory trait of impulsivity and shows both high internal consistency α = 0.79−0.83 and high reproducibility r = 0.85 [32,33]. When conducted online, self-report measures of impulsivity have been shown to be more strongly related to real-world overt behaviour than unnaturalistic behavioural testing procedures, so they were deemed suitable for the current study [34].
Furthermore, the BIS-11 incorporates six first-, and three second-order subscale factors incorporating both personality and behavioural aspects in order to determine the contribution of each toward the overall level of impulsiveness [32]. The first-order factors include attention, cognitive instability, motor, perseverance, cognitive complexity, and self-control. The second-order factors include attentional, motor, and non-planning. A detailed description of the BIS-11 items and factor loadings is provided in Appendix A Table A1.
Items on the BIS-11 are scored on a 4-point Likert scale: Rarely/Never = 1; Occasionally = 2; Often = 3; and Almost Always/Always = 4. Scores were calculated as the sum of responses for all 30 items, resulting in a raw total between 30 to 120. Previously, a total score of 74, one standard deviation above the mean reported by Patton et al. [32], was used to label someone as impulsive [32,33]. Stanford et al. [33] has since concluded that a total score of 72 or more is troublesome and symptomatic of high impulsivity. The current study used the same cut-off points for scoring as suggested by Stanford et al. [33]: highly impulsive—higher than or equal to 72; within the normal range—between 52 and 71; and low in impulsiveness or highly controlled—lower than or equal to 51 [33]. Although most studies only calculate total BIS-11 scores, because of the multidimensional nature of trait impulsivity, Stanford et al. [33] advised that second-order factors should be analysed and interpreted separately for a more accurate measure of participants’ overall level of impulsiveness. Used successfully in prior research [35], the method used to derive cut-off scores for BIS-11 second-order factors was to sum all item responses relating specifically to each of the three sub-dimensions, with higher scores representing higher impulsiveness: attentional, motor, and non-planning were scored from possible totals of 32, 44, and 44, respectively.

2.4. Recruitment and Data Collection

Participant data were collected by distributing a Qualtrics survey platform link via posts to non-diet-specific online communities and interest groups relating to food, diet, lifestyle, and recipe swapping. Stratified targeting of specific groups of vegans and vegetarians was later included in an attempt to equalise group numbers. Upon following the survey link, participants were provided information regarding the average time to complete, anonymity assurance, the right to withdraw, contact details for the principal investigator, the corresponding research integrity and ethics team, and the research topic (diet and self-regulation). The hypotheses were not disclosed to avoid biased, defensive, or planned participant responses [36]. Informed consent was indicated via a forced response function within the survey information page, prompting a binary response: ‘I consent/I do not consent’.
In the case of a non-consensual response, participants could still explore elements within the survey content, increasing the potential for obtaining reconsidered consent. In either case, the data exported from Qualtrics flagged non-consensual responses for easy identification and subsequent removal from the participant pool. No respondent IP addresses, location data, personal or identifying information such as names, phone numbers, residential or postal addresses were collected.
For the BIS-11 component, patients were encouraged to answer quickly and honestly each of the 30 questions relating to attentional (Att2nd; I often have extraneous thoughts when thinking), motor (Mot2nd; I do things without thinking), or non-planning (NonPl2nd; I am more interested in the present than the future) second-order factors. An external link provided within the Qualtrics platform enabled access to the second PUFA FFQ component. For the PUFA FFQ component, participants were instructed to indicate their estimated dietary intakes of various foods listed, including portion size and frequency of consumption. Comprising the first three digits of their unique GroupID (later used to pair BIS-11 and PUFA FFQ responses appropriately), participants were instructed to identify their diet preference as either NR = non-restricted, VTN = vegetarian, or VGN = vegan. Upon completing the second PUFA FFQ component, participants provided a one-page summary of their estimated total omega-3 consumption (expressed as mg) per day.
Although ethical risk was deemed negligible regarding participants following vegan and vegetarian diets, content disclosure was provided regarding questions relating to meat products. This transparency was necessary because many individuals who follow restrictive diets are guided by deeply held morals more than health concerns or perceived benefits [37]. The option was provided to either skip these questions or discontinue participation. However, these questions were retained for those on unrestricted diets given the observations that meat contains both omega-6 and omega-3 [38].

2.5. Statistical Analysis

The following analyses, using SPSS 28 [39], were conducted to investigate the possible association between estimated dietary intakes of omega-3 and self-reported measures of trait impulsiveness between three dietary preferences. The four ANOVAs conducted for normally distributed data were related to BIS scores. The between-subject variable was dietary preference: non-restricted (NR), vegetarian (VTN), and vegan (VGN). Dependent variables analysed for interpretation included the BIS total raw scores and BIS second-order factors: Att2nd, Mot2nd, and Nonpl2nd. A further four non-parametric analyses followed using the Kruskal–Wallis test. LCPUFA-dependent variables included omega-3 total combined (EPA, DPA, DHA), omega-3 EPA, omega-3 DHA, and omega-6 total (LA, AA).

3. Results

The participants that completed both the PUFA FFQ and the BIS (n = 333) consisted of non-restricted (NR; n = 212; 63.7%), vegetarian (VTN; n = 45; 13.5%), and vegan (VGN; n = 76; 22.8%). Females (n = 302) significantly outnumbered males (n = 31) among the participants (90.7%). Ages ranged from 19 to 65 years, and the majority were between 45 and 49 years of age (14.4%). Both the mean and median age groups fell between 40 and 44 years of age. Additional descriptive data are reported as mean ± standard deviation, while non-parametric test results are reported using median values. No exploration was conducted between gender groups for either FFQ intake estimates or BIS scores, as the gender sample size difference was too great for any meaningful comparison.
Before analysis, visual inspection of histograms, normal Q-Q plots, and box plots indicated heavy outliers in the data and extreme positive skewness across groups for FFQ (totals and separate omega-3 and omega-6) intake estimates. Attempted transformations using Log10 and SqRt functions were unsuccessful. Calculated measures of skewness and kurtosis for FFQ estimated intakes indicated a violation of normality. Shapiro–Wilk’s test further confirmed a significant departure from normality (p < 0.001) for FFQ estimated intakes across all three groups and for estimated intakes of omega-3 LCPUFAs (EPA, DPA, DHA), and omega-6 LCPUFAs (LA, AA) as both separate and combined totals.
The visual inspection of histograms, normal Q-Q plots, and box plots indicated that BIS scores appeared evenly distributed across all groups, apart from the BIS Att2nd scores for NR with skewness of 0.725 (SE = 0.167). However, considering absolute values for skewness, visual inspection, and sample size, this was accepted as normally distributed [40]. Shapiro–Wilk’s test confirmed normalcy for the distribution of total and second-order factor BIS scores across groups [41].
In consideration of unbalanced group sizes, data considered as both normally distributed and meeting the homogeneity assumption were evaluated using a one-way ANOVA where Hochberg’s GT2 served as the post hoc procedure for any significant findings [42]. All non-parametric data were evaluated for stochastic dominance using a Kruskal–Wallis test, followed by Dunn’s (1964) test with a Bonferroni adjusted p-value calculated as 0.05/3, resulting in a significance threshold of 0.017 [43]. While the examination of data not specified a priori leads to the risk of type 2 errors, this is usually associated with less conservative probability estimates, such as p = 0.05. Therefore, the robust coefficient of p < 0.002 attenuates the risks associated with post hoc analysis.

3.1. LCPUFA Intakes

The distributions of the omega-3 LCPUFA intakes (and EPA and DHA) were similar for all 3 diet groups, as assessed via the visual inspection of a boxplot. Table 1 shows the results of median LCPUFA intakes.
Total omega-3 LCPUFA (EPA, DPA, DHA) intakes were 14-fold higher (p < 0.001) in people consuming the non-restricted diet compared to those consuming vegetarian diet. The EPA intakes were 17.5-fold higher (p = 0.001) in those consuming the non-restricted diet compared to those consuming the vegetarian diet and the DHA intakes were 11-fold higher (p < 0.001) in those consuming the non-restricted diet compared to those consuming the vegetarian diet.
The total omega-6 (LA and AA) intakes in those consuming the vegan diet were 1.5-fold higher (p = 0.002) than those consuming the non-restricted diet and 1.7-fold higher (p = 0.002) than those consuming the vegetarian diet.

3.2. BIS-11 Scores

Table 2 shows the total BIS-11 and the second-order factors scores from the non-restricted, vegetarian and vegan groups.
Self-reported ratings of impulsivity (BIS-11 total scores) showed no difference between the three groups. The second-order factor self-reported ratings of Att2nd were highest (p = 0.002) in the vegan group and approximately 10% higher than the other two diets groups.

4. Discussion

This cross-sectional study investigated the association between omega-3 LCPUFA separate and combined total intakes and total and sub-dimensional self-reported measures of trait impulsiveness among 333 healthy adults across three diets: non-restricted, vegetarian, and vegan. The hypotheses were supported by the vegan and vegetarian groups showing significantly lower omega-3 LCPUFA dietary intakes and scoring comparatively higher in self-reported impulsiveness. While group means for both total and second-order factor BIS-11 scores fell within the normal range, evidence was provided of an association between lower dietary intake of omega-3 LCPUFAs (EPA, DPA, DHA) and higher scores on the BIS-11 second-order factor of attention for vegans (η2 = 0.036).
Although less proportional in strength, this finding corresponds to existing research demonstrating a negative correlation between omega-3 LCPUFA status and lower attentional inhibition in men [44], women [12] and children [45]. Additionally, using the same measure of impulsiveness (BIS-11), genetic studies have found an association between allelic variations in dopamine D2 receptor genes and attentional impulsiveness [46]. Research has demonstrated that supplementation with omega-3 PUFAs increases brain activation in prefrontal areas associated with attention [47] and has clinically meaningful effects in the management of attention deficit hyperactivity disorder [48]. It is likely that deficits in omega-3 LCPUFA intake associated with dietary choice impairs prefrontal activation; however, further investigation may be warranted to fully understand the role of omega-3 LCPUFAs specific to the attentional inhibition aspects of trait impulsiveness.
Both AA and DHA are the main PUFAs in the brain and both are required for neurological development as well as throughout the lifespan [22]. It is estimated that 90% of omega-3 PUFAs in the brain are DHA [49]. Humans can synthesise AA from LA; however, the synthesis of DHA from ALA is limited [50]. Certainly, in children with amino acid metabolism disorders who are treated with a protein-restricted diet and hence have an extremely limited consumption of AA, their erythrocyte levels of AA are comparable to healthy children, suggesting that these children can convert LA to AA [51]. However, these same children do not convert ALA to DHA, as their DHA levels are 30% lower compared to healthy children [51]. Therefore, it is no surprise that people consuming a vegan/vegetarian diet have no/little DHA in their diet and subsequently their omega-3 status is low [24].
Randomised placebo-controlled trials have shown that omega-3 supplementation can improve memory and reaction time in young healthy adults [52] and benefit mental health in older people with mild cognitive impairment [53], suggesting that omega-3 conserves brain function as humans age. The possible mechanisms for the health benefits of omega-3 include improved neural membrane stability, improved serotonin and dopamine transmission, anti-inflammatory effects and pro-resolving inflammation [54].
Impulsivity has been identified as a core feature of attention deficit hyperactivity disorder (ADHD), as noted in the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition [2]. Numerous authors have identified an association between ADHD and aggressive behaviour [55,56], prompting research into lifestyle-related preventative interventions, such as dietary management [21,44,57,58].
Additionally, the significant main effects found concerning lower omega-3 LCPUFA intakes among vegans and vegetarians compared with non-restricted diets were consistent with numerous studies, thus demonstrating the need for supplementation in restrictive diets [59,60].
As fish consumption is excluded for those adhering to vegan or vegetarian diets (with the exception of pesco-vegetarians), an alternative source is microalgae and seaweed. However, the levels of EPA and DHA found in these plants are significantly lower than the levels found in fish due to the far lower fat concentrations [61]. Additionally, restricted dieters must rely on the inefficient endogenous production of EPA, and especially DHA, through the consumption of plant-based foods containing the precursor ALA [62]. The next available alternative for those adhering to preferential diets is n-3 LCPUFA supplementation in oil, powder, or capsule form including algal oil capsules. Because of their low cost, global applicability, and minimal to negligible side effects, it would be valuable to identify nutrients capable of treating mental health illnesses as either a complement to traditional medicines or a substitute [9,63].
  • Implications for future research
The current study recognises encouraging results from clinical trials [47,64] involving the supplementation of omega-3 LCPUFAs showing improvements in cognitive functioning and impulse control, necessary for decision-making and emotional regulation. Evidence shows that disproportionate levels of DHA in membrane phospholipids (due to omega-3 deficiency, or overconsumption of omega-6) disrupt molecular regulation, resulting in an increased risk of neurological disorders wherein impulsivity is a key characteristic [62]. Nutritionists and lipidologists have consistently emphasized the need to consider supplementation in diets where the consumption of fish is excluded [21,24,60].
Collaborative efforts pursuant to evidence-based, transparent, beneficent, and non-maleficent research are crucial for advancing progress in managing and treating mental health conditions [65]. The anticipated benefits of the current research include providing direct and applicable support in the common pursuit of increased practical significance of findings for future similar studies—specifically, studies that include self-report measures as part of their methodology. Furthermore, any produced benefits may likely flow to research investigating non-pharmacological treatments, such as algal omega-3 LCPUFA supplementation, to complement traditional medicines for impulsivity-related conditions or to people who follow preferential or restricted diets.
  • Study limitations
One limitation of this study is the lack of biomarkers. Ideally, and for greater accuracy, the use of biomarkers in research is commonly used. However, within the ethical and practical constraints of the present study, the PUFA FFQ was validated against blood biomarkers and was shown to be both reproducible and valid as a measure of omega-3 and omega-6 intakes [28,29,30].
Unsupervised, online questionnaires theoretically provide a sense of privacy for the participant and are assumed to elicit more candid responses [66]. However, this is not always the case, mainly when questions of a highly sensitive, intrusive, or morally questionable nature are presented [66,67]. The exclusionary nature of vegan and vegetarian diets often attracts disproportionate scrutiny in health research compared to non-restricted diets and is often labelled as nutrient-deficient and incongruent with mainstream health guidelines [37]. As such, some degree of defensiveness and or inaccurate reporting is possible due to the perceived bias in health research.
The validity of self-report questionnaires such as the BIS-11 and PUFA FFQ used in this study relies on the authenticity of participant responses. Accordingly, this study attempted to strike an ethical balance between research transparency and socially desirable responses by withholding the expected relationship between restrictive diets and higher impulsivity. Despite these efforts, it is plausible that vegans and vegetarians may have responded to BIS-11 questions more cautiously regarding their dietary preferences. Described as a biased or primed response, negative stigma poses a significant barrier in capturing accurate data when using self-report measures, especially among respondents who perceive any content as judgemental or a threat to their constitution [68].
A final limitation was the potential for other substances that could regulate mental health were not considered.

5. Conclusions

Both vegan and vegetarian groups had significantly lower omega-3 LCPUFA dietary intakes than the non-restricted dietary group, and those on the vegan diets scored significantly higher than the other groups regarding the second-order attentional aspect of self-reported impulsiveness. These findings highlight the potential relationships between dietary restrictions, lower omega-3 LCPUFA intakes and some aspects of impulsiveness, which should be investigated in subsequent larger longitudinal studies that utilise objective measures of impulsivity.

Author Contributions

Conceptualization, M.K.B. and B.J.M.; methodology, R.C.; formal analysis, R.C.; investigation, R.C.; resources, M.K.B. and B.J.M.; data curation, R.C.; writing—original draft preparation, M.K.B., R.C.; writing—review and editing, M.K.B., R.C., J.C.D.M., D.B. and B.J.M.; supervision, M.K.B.; project administration, M.K.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Human Research Ethics Committee of the Charles Darwin University, Darwin, Australia (H21040 Approved 15 June 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

Data are available upon reasonable request from the first author.

Conflicts of Interest

The authors declare no conflicts of interest.

Appendix A

Table A1. BIS-11 Items depicting first- and second-order factor loadings [30].
Table A1. BIS-11 Items depicting first- and second-order factor loadings [30].
Item No.Item ContentFirst-Order FactorSecond-Order Factor
5I don’t “pay attention”AttentionAttentional
9 *I concentrate easilyAttentionAttentional
11I “squirm” at plays and lecturesAttentionAttentional
20 *I am a steady thinkerAttentionAttentional
28I am restless at the theatreAttentionAttentional
6I have racing thoughtsCognitive InstabilityAttentional
24I change hobbiesCognitive InstabilityAttentional
26I often have extraneous thoughtsCognitive InstabilityAttentional
2I do things without thinkingMotorMotor
3I make up my mind quicklyMotorMotor
4I am happy-go-luckyMotorMotor
17I act “on impulse”MotorMotor
19I act on the spur of the momentMotorMotor
22I buy things on impulseMotorMotor
25I spend or charge more than I ownMotorMotor
16I change jobsPerseveranceMotor
21I change residencesPerseveranceMotor
23I can only think about one thing at a timePerseveranceMotor
30 *I am future-orientedPerseveranceMotor
10 *I save regularlyCognitive ComplexityNon-Planning
15 *I like to think about complex problemsCognitive ComplexityNon-Planning
18I get easily bored when solving thought problemsCognitive ComplexityNon-Planning
27I am more interested in the present than the futureCognitive ComplexityNon-Planning
29 *I like puzzlesCognitive ComplexityNon-Planning
1 *I plan tasks carefullySelf-ControlNon-Planning
7 *I plan trips ahead of timeSelf-ControlNon-Planning
8 *I am self-controlledSelf-ControlNon-Planning
12 *I am a careful thinkerSelf-ControlNon-Planning
13 *I plan for job securitySelf-ControlNon-Planning
14I say things without thinkingSelf-ControlNon-Planning
Note. * indicates reverse-scored items.

References

  1. Korponay, C.; Koenigs, M. Gray matter correlates of impulsivity in psychopathy and in the general population differ by kind, not by degree: A comparison of systematic reviews. Soc. Cogn. Affect. Neurosci. 2021, 16, 683–695. [Google Scholar] [CrossRef] [PubMed]
  2. American Psychiatric Association. Diagnostics and Statistical Manual of Mental Disorders: DSM-5, 5th ed.; American Psychiatric Association: Washington, DC, USA, 2013. [Google Scholar]
  3. Darcey, V.L.; McQuaid, G.A.; Fishbein, D.H.; VanMeter, J.W. Dietary Long-Chain Omega-3 Fatty Acids Are Related to Impulse Control and Anterior Cingulate Function in Adolescents. Front. Neurosci. 2018, 12, 1012. [Google Scholar] [CrossRef]
  4. Sonuga-Barke, E.J.; Brandeis, D.; Cortese, S.; Daley, D.; Ferrin, M.; Holtmann, M.; Stevenson, J.; Danckaerts, M.; Van der Oord, S.; Döpfner, M.; et al. Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments. Am. J. Psychiatry 2013, 170, 275–289. [Google Scholar] [CrossRef]
  5. Ahn, J.; Ahn, H.S.; Cheong, J.H.; Dela Pena, I. Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy. Neural Plast. 2016, 2016, 1320423. [Google Scholar] [CrossRef] [PubMed]
  6. Bozzatello, P.; De Rosa, M.L.; Rocca, P.; Bellino, S. Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology. Int. J. Mol. Sci. 2020, 21, 6042. [Google Scholar] [CrossRef]
  7. Bellino, S.; Bozzatello, P.; Badino, C.; Mantelli, E.; Rocca, P. Efficacy of Polyunsaturated Fatty Acids (PUFAs) on Impulsive Behaviours and Aggressiveness in Psychiatric Disorders. Int. J. Mol. Sci. 2021, 22, 620. [Google Scholar] [CrossRef] [PubMed]
  8. Gajos, J.M.; Beaver, K.M. The effect of omega-3 fatty acids on aggression: A meta-analysis. Neurosci. Biobehav. Rev. 2016, 69, 147–158. [Google Scholar]
  9. Hibbeln, J.R.; Ferguson, T.A.; Blasbalg, T.L. Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: Opportunities for intervention. Int. Rev. Psychiatry 2006, 18, 107–118. [Google Scholar] [PubMed]
  10. Parletta, N.; Milte, C.M.; Meyer, B.J. Nutritional modulation of cognitive function and mental health. J. Nutr. Biochem. 2013, 24, 725–743. [Google Scholar] [PubMed]
  11. Kean, J.D.; Sarris, J.; Scholey, A.; Silberstein, R.; Downey, L.A.; Stough, C. Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): A randomised, double-blind, placebo-controlled trial. Psychopharmacology 2017, 234, 403–420. [Google Scholar]
  12. Cook, R.L.; Parker, H.M.; Donges, C.E.; O’Dwyer, N.J.; Cheng, H.L.; Steinbeck, K.S.; Cox, E.P.; Franklin, J.L.; Garg, M.L.; O’Connor, H.T. Omega-3 polyunsaturated fatty acids status and cognitive function in young women. Lipids Health Dis. 2019, 18, 194. [Google Scholar] [PubMed]
  13. Reddy, R.D.; Keshavan, M.S.; Yao, J.K. Reduced Red Blood Cell Membrane Essential Polyunsaturated Fatty Acids in First Episode Schizophrenia at Neuroleptic-Naive Baseline. Schizophr. Bull. 2004, 30, 901–911. [Google Scholar] [CrossRef] [PubMed]
  14. Hsu, M.-C.; Huang, Y.-S.; Ouyang, W.-C. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: Possible mechanisms. Lipids Health Dis. 2020, 19, 159. [Google Scholar] [PubMed]
  15. Patrick, R.P.; Ames, B.N. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: Relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015, 29, 2207–2222. [Google Scholar] [CrossRef] [PubMed]
  16. Pan, N.; Wang, S.; Zhao, Y.; Lai, H.; Qin, K.; Li, J.; Biswal, B.B.; Sweeney, J.A.; Gong, Q. Brain gray matter structures associated with trait impulsivity: A systematic review and voxel-based meta-analysis. Hum. Brain Mapp. 2021, 42, 2214–2235. [Google Scholar] [CrossRef] [PubMed]
  17. Cooper, R.E.; Tye, C.; Kuntsi, J.; Vassos, E.; Asherson, P. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis. J. Affect. Disord. 2016, 190, 474–482. [Google Scholar] [CrossRef] [PubMed]
  18. Dalley, J.W.; Roiser, J.P. Dopamine, serotonin and impulsivity. Neuroscience 2012, 215, 42–58. [Google Scholar] [PubMed]
  19. Healy-Stoffel, M.; Levant, B. N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders. CNS Neurol. Disord. Drug Targets 2018, 17, 216–232. [Google Scholar] [CrossRef] [PubMed]
  20. Sun, G.; Simonyi, A.; Fritsche, K.L.; Chuang, D.Y.; Hannink, M.; Gu, Z.; Greenlief, C.M.; Yao, J.K.; Lee, J.C.; Beversdorf, D.Q. Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins Leukot. Essent. Fat. Acids 2017, 136, 3–13. [Google Scholar]
  21. Meyer, B.J. Australians are not Meeting the Recommended Intakes for Omega-3 Long Chain Polyunsaturated Fatty Acids: Results of an Analysis from the 2011–2012 National Nutrition and Physical Activity Survey. Nutrients 2016, 8, 111. [Google Scholar] [CrossRef] [PubMed]
  22. Weiser, M.J.; Butt, C.M.; Mohajeri, M.H. Docosahexaenoic Acid and Cognition throughout the Lifespan. Nutrients 2016, 8, 99. [Google Scholar]
  23. Simopoulos, A.P. Evolutionary Aspects of Diet: The Omega-6/Omega-3 Ratio and the Brain. Mol. Neurobiol. 2011, 44, 203–215. [Google Scholar] [PubMed]
  24. Burdge, G.C.; Tan, S.Y.; Henry, C.J. Long-chain n-3 PUFA in vegetarian women: A metabolic perspective. J. Nutr. Sci. 2017, 6, e58. [Google Scholar] [CrossRef] [PubMed]
  25. Wang, X.; Cheng, Z. Cross sectional studies: Strengths, weaknesses and recommendations. Chest 2020, 158, S65–S71. [Google Scholar] [CrossRef] [PubMed]
  26. Faul, F.; Erdfelder, E.; Lang, A.-G.; Buchner, A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 2007, 39, 175–191. [Google Scholar]
  27. Elfil, M.; Negida, A. Sampling methods in Clinical Research; an Educational Review. Emergency 2017, 5, e52. [Google Scholar] [PubMed]
  28. Sullivan, B.L.; Williams, P.G.; Meyer, B.J. Biomarker Validation of a Long-Chain Omega-3 Polyunsaturated Fatty Acid Food Frequency Questionnaire. Lipids 2006, 41, 845–850. [Google Scholar] [CrossRef]
  29. Sullivan, B.L.; Brown, J.; Williams, P.G.; Meyer, B.J. Dietary validation of a new Australian food-frequency questionnaire that estimates long-chain n-3 polyunsaturated fatty acids. Br. J. Nutr. 2008, 99, 660–666. [Google Scholar] [CrossRef] [PubMed]
  30. Swierk, M.; Williams, P.G.; Wilcox, J.; Russell, K.G.; Meyer, B.J. Validation of an Australian electronic food frequency questionnaire to measure polyunsaturated fatty acid intake. Nutrition 2011, 27, 641–646. [Google Scholar] [CrossRef]
  31. Meyer, B.J.; Swierk, M.; Russell, K.G. Assessing long-chain omega-3 polyunsaturated fatty acids: A tailored food-frequency questionnaire is better. Nutrition 2013, 29, 491–496. [Google Scholar] [CrossRef] [PubMed]
  32. Patton, J.H.; Stanford, M.S.; Barratt, E.S. Factor structure of the barratt impulsiveness scale. J. Clin. Psychol. 1995, 51, 768–774. [Google Scholar] [CrossRef] [PubMed]
  33. Stanford, M.S.; Mathias, C.W.; Dougherty, D.M.; Lake, S.L.; Anderson, N.E.; Patton, J.H. Fifty years of the Barratt Impulsiveness Scale: An update and review. Personal. Individ. Differ. 2009, 47, 385–395. [Google Scholar]
  34. Eisenberg, I.W.; Bissett, P.G.; Zeynep Enkavi, A.; Li, J.; MacKinnon, D.P.; Marsch, L.A.; Poldrack, R.A. Uncovering the structure of self-regulation through data-driven ontology discovery. Nat. Commun. 2019, 10, 2319. [Google Scholar] [PubMed]
  35. Riley, M.; Bakeberg, M.; Byrnes, M.; Jefferson, A.; Ghosh, S.; Stell, R.; Mastaglia, F.L.; Hince, D.; Anderton, R.S. Demographic and Clinical Predictors of Trait Impulsivity in Parkinson’s Disease Patients. Park. Dis. 2018, 2018, 9472120. [Google Scholar] [CrossRef] [PubMed]
  36. Robinson, M.A. Using multi-item psychometric scales for research and practice in human resource management. Hum. Resour. Manag. 2018, 57, 739–750. [Google Scholar] [CrossRef]
  37. Jordan, A.K.; Dial, L.A.; Barnhart, W.R.; Studer-Perez, E.I.; Kamath, S.; Musher-Eizenman, D.R. Fussy, fad, and frustrating? Stigma toward picky eaters and popular dieters by peers. Stigma Health 2021, 8, 409–415. [Google Scholar] [CrossRef]
  38. Howe, P.; Meyer, B.; Record, S.; Baghurst, K. Dietary intake of long-chain omega-3 polyunsaturated fatty acids: Contribution of meat sources. Nutrition 2006, 22, 47–53. [Google Scholar] [CrossRef] [PubMed]
  39. IBM SPSS Statistics for Windows; Version 28; IBM Corp: Armonk, NY, USA, 2022.
  40. Allen, P.; Bennett, K.; Heritage, B. SPSS Statistics: A Practical Guide, 4th ed.; Cengage: Victoria, Australia, 2019. [Google Scholar]
  41. Shapiro, S.S.; Wilk, M.B. An analysis of variance test for normality (complete samples). Biometrika 1965, 52, 591–611. [Google Scholar] [CrossRef]
  42. Sauder, D.C.; DeMars, C.E. An Updated Recommendation for Multiple Comparisons. Adv. Methods Pract. Psychol. Sci. 2019, 2, 26–44. [Google Scholar] [CrossRef]
  43. Dinno, A. Nonparametric Pairwise Multiple Comparisons in Independent Groups using Dunn’s Test. Stata J. 2015, 15, 292–300. [Google Scholar] [CrossRef]
  44. Meyer, B.J.; Byrne, M.K.; Collier, C.; Parletta, N.; Crawford, D.; Winberg, P.C.; Webster, D.; Chapman, K.; Thomas, G.; Dally, J.; et al. Baseline omega-3 index correlates with aggressive and attention deficit disorder behaviours in adult prisoners. PLoS ONE 2015, 10, e0120220. [Google Scholar]
  45. Parletta, N.; Niyonsenga, T.; Duff, J. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls. PLoS ONE 2016, 11, e0156432. [Google Scholar]
  46. Taylor, J.B.; Cummins, T.D.R.; Fox, A.M.; Johnson, B.P.; Tong, J.H.; Visser, T.A.W.; Hawi, Z.; Bellgrove, M.A. Allelic variation in dopamine D2 receptor gene is associated with attentional impulsiveness on the Barratt Impulsiveness Scale (BIS-11). World J. Biol. Psychiatry 2018, 19 (Suppl. 2), S75–S83. [Google Scholar] [PubMed]
  47. Bauer, I.; Hughes, M.; Rowsell, R.; Cockerell, R.; Pipingas, A.; Crewther, S.; Crewther, D. Omega-3 supplementation improves cognition and modifies brain activation in young adults. Hum. Psychopharmacol. Clin. Exp. 2014, 29, 133–144. [Google Scholar]
  48. Bos, D.J.; Oranje, B.; Veerhoek, E.S.; Van Diepen, R.M.; Weusten, J.M.; Demmelmair, H.; Koletzko, B.; de Sain-van der Velden, M.G.; Eilander, A.; Hoeksma, M.; et al. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder. Neuropsychopharmacology 2015, 40, 2298–2306. [Google Scholar] [PubMed]
  49. Brenna, J.T.; Diau, G.-Y. The Influence of Dietary Docosahexaenoic Acid and Arachidonic Acid on Central Nervous System Polyunsaturated Fatty Acid Composition. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77, 247–250. [Google Scholar] [CrossRef]
  50. Burdge, G.C.; Jones, A.E.; Wootton, S.A. Eicosapentaenoic and Docosapentaenoic Acids are the Principal Products of Alpha-Linolenic Acid Metabolism in Young Men. Br. J. Nutr. 2002, 88, 355–363. [Google Scholar] [CrossRef] [PubMed]
  51. Vlaardingerbroek, H.; Hornstra, G.; de Koning, T.J.; Smeitink, J.A.; Bakker, H.D.; de Klerk, H.B.; Rubio-Gozalbo, M.E. Essential Polyunsaturated Fatty Acids in Plasma and Erythrocytes of Children with Inborn Errors of Amino Acid Metabolism. Mol. Genet. Metab. 2006, 88, 159–165. [Google Scholar] [CrossRef] [PubMed]
  52. Stonehouse, W.; Conlon, C.A.; Podd, J.; Minihane, A.M.; Haskell, C.; Kennedy, D. DHA Supplementation Improved Both Memory and Reaction Time in Healthy Young Adults: A Randomized Controlled Trial. Am. J. Clin. Nutr. 2013, 97, 1134–1143. [Google Scholar] [CrossRef] [PubMed]
  53. Sinn, N.; Milte, C.M.; Street, S.J.; Buckley, J.D.; Coates, A.M.; Petkov, J.; Howe, P.R.C. Effect of n-3 fatty acids, EPA v. DHA, on Depressive Symptoms, Quality of Life, Memory and Executive Function in Older Adults with Mild Cognitive Impairment: A 6-Month Randomised Controlled Trial. Br. J. Nutr. 2012, 107, 1682–1693. [Google Scholar] [CrossRef] [PubMed]
  54. DiNicolantonio, J.J.; O’Keefe, J.H. The Importance of Marine Omega-3s for Brain Development and the Prevention and Treatment of Behavior, Mood, and Other Brain Disorders. Nutrients 2020, 12, 2333. [Google Scholar]
  55. Dowson, J.H.; Blackwell, A.D. Impulsive Aggression in Adults with Attention Deficit/Hyperactivity Disorder. Acta Psychiatr. Scand. 2010, 121, 103–110. [Google Scholar] [CrossRef] [PubMed]
  56. Wender, P.H.; Wolf, L.E.; Wasserstein, J. Adults with ADHD: An Overview in Adult Attention Deficit Disorder: Brain Mechanisms and Life Outcomes; New York Academy of Sciences: New York, NY, USA, 2001; pp. 1–16. [Google Scholar]
  57. Gesch, C.B.; Hammond, S.M.; Hampson, S.E.; Eves, A.; Crowder, M.J. Influence of Supplementary Vitamins, Minerals and Essential Fatty Acids on the Behaviour of Young Adults Prisoners—Randomised, Placebo-Controlled Trial. Br. J. Psychiatry 2002, 181, 22–28. [Google Scholar] [CrossRef]
  58. Zaalberg, A.; Nijman, H.; Bulten, E.; Stroosma, L.; van der Staak, C. Effects of Nutritional Supplements on Aggression, Rule-Breaking, and Psychopathology Among Adults Prisoners. Aggress. Behav. 2010, 36, 117–126. [Google Scholar] [PubMed]
  59. Lukasiewicz, M.; Filipiak-Florkiewicz, A.; Florkiewicz, A.; Topolska, K.; Zięć, G.; Czosnowska, B. Comparison of the Consumption of N-3 and N-6 Acids by Adults Following a Vegetarian and Traditional Diet. In Proceedings of the 1st International Electronic Conference on Food Science and Functional Foods, Online, 10–25 November 2020. [Google Scholar]
  60. Kornsteiner, M.; Singer, I.; Elmadfa, I. Very Low n–3 Long-Chain Polyunsaturated Fatty Acid Status in Austrian Vegetarians and Vegans. Ann. Nutr. Metab. 2008, 52, 37–47. [Google Scholar] [CrossRef] [PubMed]
  61. Davis, B.C.; Kris-Etherton, P.M. Achieving optimal essential fatty acid status in vegetarians: Current knowledge and practical implications. Am. J. Clin. Nutr. 2003, 78, 640S–646S. [Google Scholar]
  62. Djuricic, I.; Calder, P.C. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021. Nutrients 2021, 13, 2421. [Google Scholar] [PubMed]
  63. Bloch, M.H.; Qawasmi, A. Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis. J. Am. Acad. Child Adolesc. Psychiatry 2011, 50, 991–1000. [Google Scholar] [PubMed]
  64. Fontani, G.; Corradeschi, F.; Felici, A.; Alfatti, F.; Migliorini, S.; Lodi, L. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur. J. Clin. Investig. 2005, 35, 691–699. [Google Scholar]
  65. Israel, M. Research Ethics and Integrity for Social Scientists: Beyond Regulatory Compliance, 2nd ed.; Sage Publications Ltd.: London, UK, 2015; Available online: https://methods.sagepub.com/book/research-ethics-and-integrity-for-social-scientists-2e (accessed on 28 November 2023).
  66. Gnambs, T.; Kaspar, K. Socially Desirable Responding in Web-Based Questionnaires: A Meta-Analytic Review of the Candor Hypothesis. Assessment 2017, 24, 746–762. [Google Scholar] [PubMed]
  67. Yan, T. Consequences of Asking Sensitive Questions in Surveys. Annu. Rev. Stat. Its Appl. 2021, 8, 109–127. [Google Scholar] [CrossRef]
  68. Dobersek, U.; Wy, G.; Adkins, J.; Altmeyer, S.; Krout, K.; Lavie, C.J.; Archer, E. Meat and mental health: A systematic review of meat abstention and depression, anxiety, and related phenomena. Crit. Rev. Food Sci. Nutr. 2021, 61, 622–635. [Google Scholar] [CrossRef] [PubMed]
Table 1. LCPUFA intakes (median intakes in grams).
Table 1. LCPUFA intakes (median intakes in grams).
Non-Restricted Diet (n = 212)Vegetarian Diet
(n = 45)		Vegan Diet
(n = 76)		χ2(2)p Value
Total Omega-3 intakes (EPA + DPA + DHA)0.347 a0.024 b0.000 c184<0.001
EPA intakes0.105 a0.006 b0.000 c1820.001
DHA intakes0.141 a0.013 b0.000 c166<0.001
Total Omega-6 intakes
(LA and AA)		10.70 a9.73 a16.32 b160.002
Different superscript letters indicate differences between individual groups with significance level p < 0.017.
Table 2. BIS-11 total scores and second-order factors (mean ± SD).
Table 2. BIS-11 total scores and second-order factors (mean ± SD).
Non-Restricted Diet (n = 212)Vegetarian Diet
(n = 45)		Vegan Diet (n = 76)F
(2330)		p Value
BIS-11 total scores59.9 ± 9.2460.3 ± 8.9362.9 ± 9.72.9310.055
Second order factors
Attentional
(Att2nd)		16.1 ± 3.87 a16.8 ± 4.20 a18.0 ± 4.41 b6.1930.002
Motor
(Mot2nd)		21.2 ± 3.7621.0 ± 3.4821.6 ± 3.650.3990.671
Non-planning
(NonPl2nd)		22.6 ± 4.5122.5 ± 4.2123.4 ± 4.790.8430.431
Post hoc multiple comparisons using the Hochberg’s GT2 test indicated that participants following a vegan diet had significantly higher mean Att2nd scores than the non-restricted group (p = 0.002), 95% CI [17.96, 4.41]. Different superscript letters indicate differences between individual groups with significant level p < 0.017.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Byrne, M.K.; Cook, R.; Murta, J.C.D.; Bressington, D.; Meyer, B.J. Dietary Intakes of Long-Chain Polyunsaturated Fatty Acids and Impulsivity: Comparing Non-Restricted, Vegetarian, and Vegan Diets. Nutrients 2024, 16, 875. https://doi.org/10.3390/nu16060875

AMA Style

Byrne MK, Cook R, Murta JCD, Bressington D, Meyer BJ. Dietary Intakes of Long-Chain Polyunsaturated Fatty Acids and Impulsivity: Comparing Non-Restricted, Vegetarian, and Vegan Diets. Nutrients. 2024; 16(6):875. https://doi.org/10.3390/nu16060875

Chicago/Turabian Style

Byrne, Mitchell K., Rebecca Cook, Janina C. D. Murta, Daniel Bressington, and Barbara J. Meyer. 2024. "Dietary Intakes of Long-Chain Polyunsaturated Fatty Acids and Impulsivity: Comparing Non-Restricted, Vegetarian, and Vegan Diets" Nutrients 16, no. 6: 875. https://doi.org/10.3390/nu16060875

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop